{
  "intermediate": [
    "**Patient Summary:**\n\nPatient Name: RAMANI BHASKARAN\nAge: 58 years\nGender: Female\n\n**Medical History:**\n\n1. **Prediabetes:** The Apollo Hospitals Prediabetes Risk tool has assessed a risk score of 2.5/100, indicating a low risk for undiagnosed prediabetes.\n2. **Hypertension:** The patient has hypertension, with a systolic blood pressure of 150 mmHg and a diastolic blood pressure of 80 mmHg.\n3. **Vitamin D Deficiency:** The patient has a vitamin D level of 15.4 ng/mL, which is below the normal range of 30-100 ng/mL.\n4. **Vitamin B12 Deficiency:** The patient has a vitamin B12 level of 50 pg/mL, which is below the normal range of 120-914 pg/mL.\n5. **Cervical Spondylosis:** The patient has cervical spondylosis, which is a condition characterized by wear and tear on the cervical spine.\n6. **Bilateral Carotid Plaque:** The patient has bilateral carotid plaque, which is a condition characterized by the buildup of plaque in the carotid arteries.\n\n**Lab Results:**\n\n1. **Lipid Profile:**\n\t* Total Cholesterol: 170 mg/dL (normal range: 0-199.99 mg/dL)\n\t* Triglycerides: 199 mg/dL (normal range: 0-149.99 mg/dL)\n\t* HDL Cholesterol: 43 mg/dL (normal range: 40-60 mg/dL)\n\t* LDL Cholesterol: 87.2 mg/dL (normal range: 0-100 mg/dL)\n2. **Thyroid Profile:**\n\t* Tri-Iodothyronine (T3, Total): 0.83 ng/mL (normal range: 0.7-2.04 ng/mL)\n\t* Thyroxine (T4, Total): 7.43 µg/dL (normal range: 5.48-14.28 µg/dL)\n\t* Thyroid Stimulating Hormone (TSH): 3.931 µIU/mL (normal range: 0.34-5.6 µIU/mL)\n3. **Complete Blood Count (CBC):**\n\t* Lymphocytes: 28.8% (normal range: 20-40%)\n\t* Neutrophils: 4882.2 cells/cu.mm (normal range: 2000-7000 cells/cu.mm)\n\t* Monocytes: 5.6% (normal range: 2-10%)\n\t* Eosinophils: 3.1% (normal range: 1-6%)\n\t* Basophils: 0.7% (normal range: 0-2%)\n4. **Urine Examination:**\n\t* Urine Protein: Negative\n\t* Glucose: Negative\n\t* Urine Bilirubin: Negative\n\t* Urine Ketones (Random): Negative\n\t* Urobilinogen: Normal\n\t* Blood: Negative\n\t* Nitrite: Negative\n\t* Leucocyte Esterase: Negative\n\t* Pus Cells: 1-3\n\t* Epithelial Cells: 2-4\n\t* RBC: Nil\n\t* Casts: Absent\n\t* Crystals: Absent\n\t* pH: 5.5 (normal range: 5-7.5)\n\t* Sp. Gravity: 1.025 (normal range: 1.002-1.03)\n\n**Recommendations:**\n\n1. The patient should follow a healthy diet and exercise regularly to manage her hypertension and prediabetes.\n2. The patient should take vitamin D and vitamin B12 supplements to address her deficiencies.\n3. The patient should undergo regular follow-up appointments with her healthcare provider to monitor her condition and adjust her treatment plan as needed.\n4. The patient should consider undergoing further testing, such as a carotid ultrasound, to assess the extent of her bilateral carotid plaque.\n5. The patient should follow a healthy lifestyle, including a balanced diet and regular exercise, to manage her cervical spondylosis.\n\n**Disclaimer:**\n\nThe above summary is based on the provided medical report and is subject to clinical interpretation by qualified medical professionals. The report is not subject to use for any medicolegal purpose.",
    "**Patient Summary:**\n\nBased on the provided medical report, the patient's test results are as follows:\n\n**Urine Analysis:**\n\n- Urine sample collected on 17-02-2024\n- pH: 5.5 (within normal range: 5-7.5)\n- Specific gravity: 1.025 (within normal range: 1.002-1.03)\n- RBC: NIL (no red blood cells present)\n- WBC: NIL (no white blood cells present)\n- Epithelial cells: 2-4 (within normal range)\n- Casts: ABSENT\n- Crystals: ABSENT\n- Pus cells: 1-3 (within normal range)\n\n**Complete Blood Count (CBC):**\n\n- Sample collected on 17-02-2024\n- Total Leucocyte Count (TLC): 7,900 (within normal range)\n- Haemoglobin: 12 g/dL (within normal range: 12-15 g/dL)\n- PCV: 35.90% (within normal range: 36-46%)\n- RBC count: 4.07 Million/cu.mm (within normal range: 3.8-4.8 Million/cu.mm)\n- MCV: 88.4 fL (within normal range: 83-101 fL)\n- MCH: 29.5 pg (within normal range: 27-32 pg)\n- MCHC: 33.3 g/dL (within normal range: 31.5-34.5 g/dL)\n- R.D.W: 14.6% (within normal range: 11.6-14%)\n\n**Neutrophils:**\n\n- Neutrophils: 61.8% (within normal range: 40-80%)\n\n**Vitamin D:**\n\n- Sample collected on 17-02-2024\n- Vitamin D: 15.4 ng/mL (within normal range: 30-100 ng/mL)\n\n**Glucose and HbA1c:**\n\n- Fasting glucose: 100 mg/dL (within normal range: 70-100 mg/dL)\n- HbA1c: 6.2% (within normal range: 0-0%)\n- Estimated average glucose (eAG): 131 mg/dL (within normal range: 0-0 mg/dL)\n\n**Renal Profile/Renal Function Test (RFT/KFT):**\n\n- Sample collected on 17-02-2024\n- Creatinine: 0.74 mg/dL (within normal range: 0.72-1.18 mg/dL)\n- Urea: 16.00 mg/dL (within normal range: 17-43 mg/dL)\n- Blood Urea Nitrogen: 7.5 mg/dL (within normal range: 8-23 mg/dL)\n- Uric acid: 5.90 mg/dL (within normal range: 2.6-6 mg/dL)\n- Calcium: 9.90 mg/dL (within normal range: 8.8-10.6 mg/dL)\n- Phosphorus: 4.00 mg/dL (within normal range: 2.5-4.5 mg/dL)\n- Sodium: 139 mmol/L (within normal range: 136-146 mmol/L)\n- Potassium: 4.5 mmol/L (within normal range: 3.5-5.1 mmol/L)\n- Chloride: 103 mmol/L (within normal range: 101-109 mmol/L)\n\n**Liver Function Test (LFT):**\n\n- Sample collected on 17-02-2024\n- Bilirubin, total: 0.47 mg/dL (within normal range: 0.3-1.2 mg/dL)\n- Bilirubin conjugated (direct): 0.10 mg/dL (within normal range: 0-0.19 mg/dL)\n- Bilirubin (indirect): 0.37 mg/dL (within normal range: 0-1.1 mg/dL)\n- Alanine aminotransferase (ALT/SGPT): 15 U/L (within normal range: 0-34.99 U/L)\n- Aspartate aminotransferase (AST/SGOT): 15.0 U/L (within normal range: 0-34.99 U/L)\n- Alkaline phosphatase: 67.00 U/L (within normal range: 30-120 U/L)\n- Protein, total: 7.50 g/dL (within normal range: 6.6-8.3 g/dL)\n- Albumin: 4.50 g/dL (within normal range: 3.5-5.2 g/dL)\n- Globulin: 3.00 g/dL (within normal range: 2-3.5 g/dL)\n- A/G ratio: 1.5 (within normal range: 0.9-2)\n\n**CA-125:**\n\n- Sample collected on 17-02-2024\n- CA-125: 6.3 U/mL (within normal range: 0-35 U/mL)\n\n**Apollo's Artificial Intelligence Enabled Risk Scores:**\n\n- AICVD Risk score: Low Risk\n- Pre-Diabetes Risk score: Low Risk\n- COPD Risk Assessment: Low Risk\n\n**Interpretation:**\n\nBased on the provided test results, the patient's overall health appears to be within normal limits. The CBC, urine analysis, and renal profile results are all within normal ranges. The liver function test results are also within normal limits. The patient's vitamin D levels are within normal range, and the fasting glucose and HbA1c levels are also within normal limits. The CA-125 level is within normal range. The Apollo's Artificial Intelligence Enabled Risk Scores indicate a low risk for cardiovascular disease, pre-diabetes, and COPD.\n\n**Recommendations:**\n\nBased on the provided test results, the following recommendations can be made:\n\n1. Continue to monitor the patient's vitamin D levels to ensure they remain within normal range.\n2. Continue to monitor the patient's fasting glucose and HbA1c levels to ensure they remain within normal limits.\n3. Continue to monitor the patient's liver function test results to ensure they remain within normal limits.\n4. Continue to monitor the patient's CA-125 level to ensure it remains within normal range.\n5. Continue to monitor the patient's renal function test results to ensure they remain within normal limits.\n\n**Ambiguous/Missing Information:**\n\nThere is no ambiguous or missing information in the provided medical report."
  ],
  "consolidated": "**Comprehensive Summary:**\n\n**Patient Information:**\n\n- Patient Name: RAMANI BHASKARAN\n- Age: 58 years\n- Gender: Female\n\n**Medical History:**\n\n1. **Prediabetes:** The Apollo Hospitals Prediabetes Risk tool has assessed a risk score of 2.5/100, indicating a low risk for undiagnosed prediabetes.\n2. **Hypertension:** The patient has hypertension, with a systolic blood pressure of 150 mmHg and a diastolic blood pressure of 80 mmHg.\n3. **Vitamin D Deficiency:** The patient has a vitamin D level of 15.4 ng/mL, which is below the normal range of 30-100 ng/mL.\n4. **Vitamin B12 Deficiency:** The patient has a vitamin B12 level of 50 pg/mL, which is below the normal range of 120-914 pg/mL.\n5. **Cervical Spondylosis:** The patient has cervical spondylosis, which is a condition characterized by wear and tear on the cervical spine.\n6. **Bilateral Carotid Plaque:** The patient has bilateral carotid plaque, which is a condition characterized by the buildup of plaque in the carotid arteries.\n\n**Lab Results:**\n\n1. **Lipid Profile:**\n\t* Total Cholesterol: 170 mg/dL (normal range: 0-199.99 mg/dL)\n\t* Triglycerides: 199 mg/dL (normal range: 0-149.99 mg/dL)\n\t* HDL Cholesterol: 43 mg/dL (normal range: 40-60 mg/dL)\n\t* LDL Cholesterol: 87.2 mg/dL (normal range: 0-100 mg/dL)\n2. **Thyroid Profile:**\n\t* Tri-Iodothyronine (T3, Total): 0.83 ng/mL (normal range: 0.7-2.04 ng/mL)\n\t* Thyroxine (T4, Total): 7.43 µg/dL (normal range: 5.48-14.28 µg/dL)\n\t* Thyroid Stimulating Hormone (TSH): 3.931 µIU/mL (normal range: 0.34-5.6 µIU/mL)\n3. **Complete Blood Count (CBC):**\n\t* Lymphocytes: 28.8% (normal range: 20-40%)\n\t* Neutrophils: 4882.2 cells/cu.mm (normal range: 2000-7000 cells/cu.mm)\n\t* Monocytes: 5.6% (normal range: 2-10%)\n\t* Eosinophils: 3.1% (normal range: 1-6%)\n\t* Basophils: 0.7% (normal range: 0-2%)\n4. **Urine Examination:**\n\t* Urine Protein: Negative\n\t* Glucose: Negative\n\t* Urine Bilirubin: Negative\n\t* Urine Ketones (Random): Negative\n\t* Urobilinogen: Normal\n\t* Blood: Negative\n\t* Nitrite: Negative\n\t* Leucocyte Esterase: Negative\n\t* Pus Cells: 1-3\n\t* Epithelial Cells: 2-4\n\t* RBC: Nil\n\t* Casts: Absent\n\t* Crystals: Absent\n\t* pH: 5.5 (normal range: 5-7.5)\n\t* Sp. Gravity: 1.025 (normal range: 1.002-1.03)\n\n**Renal Profile/Renal Function Test (RFT/KFT):**\n\n- Sample collected on 17-02-2024\n- Creatinine: 0.74 mg/dL (within normal range: 0.72-1.18 mg/dL)\n- Urea: 16.00 mg/dL (within normal range: 17-43 mg/dL)\n- Blood Urea Nitrogen: 7.5 mg/dL (within normal range: 8-23 mg/dL)\n- Uric acid: 5.90 mg/dL (within normal range: 2.6-6 mg/dL)\n- Calcium: 9.90 mg/dL (within normal range: 8.8-10.6 mg/dL)\n- Phosphorus: 4.00 mg/dL (within normal range: 2.5-4.5 mg/dL)\n- Sodium: 139 mmol/L (within normal range: 136-146 mmol/L)\n- Potassium: 4.5 mmol/L (within normal range: 3.5-5.1 mmol/L)\n- Chloride: 103 mmol/L (within normal range: 101-109 mmol/L)\n\n**Liver Function Test (LFT):**\n\n- Sample collected on 17-02-2024\n- Bilirubin, total: 0.47 mg/dL (within normal range: 0.3-1.2 mg/dL)\n- Bilirubin conjugated (direct): 0.10 mg/dL (within normal range: 0-0.19 mg/dL)\n- Bilirubin (indirect): 0.37 mg/dL (within normal range: 0-1.1 mg/dL)\n- Alanine aminotransferase (ALT/SGPT): 15 U/L (within normal range: 0-34.99 U/L)\n- Aspartate aminotransferase (AST/SGOT): 15.0 U/L (within normal range: 0-34.99 U/L)\n- Alkaline phosphatase: 67.00 U/L (within normal range: 30-120 U/L)\n- Protein, total: 7.50 g/dL (within normal range: 6.6-8.3 g/dL)\n- Albumin: 4.50 g/dL (within normal range: 3.5-5.2 g/dL)\n- Globulin: 3.00 g/dL (within normal range: 2-3.5 g/dL)\n- A/G ratio: 1.5 (within normal range: 0.9-2)\n\n**CA-125:**\n\n- Sample collected on 17-02-2024\n- CA-125: 6.3 U/mL (within normal range: 0-35 U/mL)\n\n**Apollo's Artificial Intelligence Enabled Risk Scores:**\n\n- AICVD Risk score: Low Risk\n- Pre-Diabetes Risk score: Low Risk\n- COPD Risk Assessment: Low Risk\n\n**Recommendations:**\n\n1. The patient should follow a healthy diet and exercise regularly to manage her hypertension and prediabetes.\n2. The patient should take vitamin D and vitamin B12 supplements to address her deficiencies.\n3. The patient should undergo regular follow-up appointments with her healthcare provider to monitor her condition and adjust her treatment plan as needed.\n4. The patient should consider undergoing further testing, such as a carotid ultrasound, to assess the extent of her bilateral carotid plaque.\n5. The patient should follow a healthy lifestyle, including a balanced diet and regular exercise, to manage her cervical spondylosis.\n\n**Ambiguous/Missing Information:**\n\nThere is no ambiguous or missing information in the provided medical report.",
  "final": "**Comprehensive Summary:**\n\n**Patient Information:**\n\n- Patient Name: RAMANI BHASKARAN\n- Age: 58 years\n- Gender: Female\n\n**Medical History:**\n\n1. **Prediabetes:** The Apollo Hospitals Prediabetes Risk tool has assessed a risk score of 2.5/100, indicating a low risk for undiagnosed prediabetes.\n2. **Hypertension:** The patient has hypertension, with a systolic blood pressure of 150 mmHg and a diastolic blood pressure of 80 mmHg.\n3. **Vitamin D Deficiency:** The patient has a vitamin D level of 15.4 ng/mL, which is below the normal range of 30-100 ng/mL.\n4. **Vitamin B12 Deficiency:** The patient has a vitamin B12 level of 50 pg/mL, which is below the normal range of 120-914 pg/mL.\n5. **Cervical Spondylosis:** The patient has cervical spondylosis, which is a condition characterized by wear and tear on the cervical spine.\n6. **Bilateral Carotid Plaque:** The patient has bilateral carotid plaque, which is a condition characterized by the buildup of plaque in the carotid arteries.\n\n**Lab Results:**\n\n1. **Lipid Profile:**\n\t* Total Cholesterol: 170 mg/dL (normal range: 0-199.99 mg/dL)\n\t* Triglycerides: 199 mg/dL (normal range: 0-149.99 mg/dL)\n\t* HDL Cholesterol: 43 mg/dL (normal range: 40-60 mg/dL)\n\t* LDL Cholesterol: 87.2 mg/dL (normal range: 0-100 mg/dL)\n2. **Thyroid Profile:**\n\t* Tri-Iodothyronine (T3, Total): 0.83 ng/mL (normal range: 0.7-2.04 ng/mL)\n\t* Thyroxine (T4, Total): 7.43 µg/dL (normal range: 5.48-14.28 µg/dL)\n\t* Thyroid Stimulating Hormone (TSH): 3.931 µIU/mL (normal range: 0.34-5.6 µIU/mL)\n3. **Complete Blood Count (CBC):**\n\t* Lymphocytes: 28.8% (normal range: 20-40%)\n\t* Neutrophils: 4882.2 cells/cu.mm (normal range: 2000-7000 cells/cu.mm)\n\t* Monocytes: 5.6% (normal range: 2-10%)\n\t* Eosinophils: 3.1% (normal range: 1-6%)\n\t* Basophils: 0.7% (normal range: 0-2%)\n4. **Urine Examination:**\n\t* Urine Protein: Negative\n\t* Glucose: Negative\n\t* Urine Bilirubin: Negative\n\t* Urine Ketones (Random): Negative\n\t* Urobilinogen: Normal\n\t* Blood: Negative\n\t* Nitrite: Negative\n\t* Leucocyte Esterase: Negative\n\t* Pus Cells: 1-3\n\t* Epithelial Cells: 2-4\n\t* RBC: Nil\n\t* Casts: Absent\n\t* Crystals: Absent\n\t* pH: 5.5 (normal range: 5-7.5)\n\t* Sp. Gravity: 1.025 (normal range: 1.002-1.03)\n\n**Renal Profile/Renal Function Test (RFT/KFT):**\n\n- Sample collected on 17-02-2024\n- Creatinine: 0.74 mg/dL (within normal range: 0.72-1.18 mg/dL)\n- Urea: 16.00 mg/dL (within normal range: 17-43 mg/dL)\n- Blood Urea Nitrogen: 7.5 mg/dL (within normal range: 8-23 mg/dL)\n- Uric acid: 5.90 mg/dL (within normal range: 2.6-6 mg/dL)\n- Calcium: 9.90 mg/dL (within normal range: 8.8-10.6 mg/dL)\n- Phosphorus: 4.00 mg/dL (within normal range: 2.5-4.5 mg/dL)\n- Sodium: 139 mmol/L (within normal range: 136-146 mmol/L)\n- Potassium: 4.5 mmol/L (within normal range: 3.5-5.1 mmol/L)\n- Chloride: 103 mmol/L (within normal range: 101-109 mmol/L)\n\n**Liver Function Test (LFT):**\n\n- Sample collected on 17-02-2024\n- Bilirubin, total: 0.47 mg/dL (within normal range: 0.3-1.2 mg/dL)\n- Bilirubin conjugated (direct): 0.10 mg/dL (within normal range: 0-0.19 mg/dL)\n- Bilirubin (indirect): 0.37 mg/dL (within normal range: 0-1.1 mg/dL)\n- Alanine aminotransferase (ALT/SGPT): 15 U/L (within normal range: 0-34.99 U/L)\n- Aspartate aminotransferase (AST/SGOT): 15.0 U/L (within normal range: 0-34.99 U/L)\n- Alkaline phosphatase: 67.00 U/L (within normal range: 30-120 U/L)\n- Protein, total: 7.50 g/dL (within normal range: 6.6-8.3 g/dL)\n- Albumin: 4.50 g/dL (within normal range: 3.5-5.2 g/dL)\n- Globulin: 3.00 g/dL (within normal range: 2-3.5 g/dL)\n- A/G ratio: 1.5 (within normal range: 0.9-2)\n\n**CA-125:**\n\n- Sample collected on 17-02-2024\n- CA-125: 6.3 U/mL (within normal range: 0-35 U/mL)\n\n**Apollo's Artificial Intelligence Enabled Risk Scores:**\n\n- AICVD Risk score: Low Risk\n- Pre-Diabetes Risk score: Low Risk\n- COPD Risk Assessment: Low Risk\n\n**Recommendations:**\n\n1. The patient should follow a healthy diet and exercise regularly to manage her hypertension and prediabetes.\n2. The patient should take vitamin D and vitamin B12 supplements to address her deficiencies.\n3. The patient should undergo regular follow-up appointments with her healthcare provider to monitor her condition and adjust her treatment plan as needed.\n4. The patient should consider undergoing further testing, such as a carotid ultrasound, to assess the extent of her bilateral carotid plaque.\n5. The patient should follow a healthy lifestyle, including a balanced diet and regular exercise, to manage her cervical spondylosis.\n\n**Ambiguous/Missing Information:**\n\nNone.\n\n**Additional Comments:**\n\nThe patient's lipid profile indicates elevated triglycerides, which may be a concern for cardiovascular health. The patient's thyroid profile is within normal limits, but the TSH level is slightly elevated, which may warrant further evaluation. The patient's CBC and urine examination results are within normal limits. The patient's renal function tests and liver function tests are also within normal limits. The patient's CA-125 level is within normal limits, which suggests that there is no evidence of ovarian cancer at this time. The patient's risk scores for cardiovascular disease, pre-diabetes, and COPD are all low, which suggests that she is at low risk for these conditions.\n\n**Medications:**\n\nThe patient's medication regimen is not specified in the provided medical report.\n\n**Imaging Studies:**\n\nThe patient's imaging studies are not specified in the provided medical report.\n\n**Follow-up:**\n\nThe patient should follow up with her healthcare provider in 6-8 weeks to monitor her condition and adjust her treatment plan as needed."
}